Efficacy and Safety of Tamibarotene (OAM80) for Alzheimer's Disease
Status:
Unknown status
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
A double blind, placebo-controlled randomized study to evaluate the efficacy and safety of
orally administered Tamibarotene to patients of Alzheimer's Disease